Modulation of β-catenin and E-cadherin interaction by Vpu increases human immunodeficiency virus type 1 particle release

Journal of Virology

Volumn 82, Issue 8, 2008, Pages 3932-3938

  Salim, Aneeza ^a   Ratner, Lee ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 8069 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; BETA CATENIN; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; CD4 ANTIGEN; CELL PROTEIN; I KAPPA B ALPHA; PROTEIN EMI1; PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VPU PROTEIN; CADHERIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; VIRUS PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; T LYMPHOCYTE; VIRUS GENE; VIRUS PARTICLE; VPU GENE; CELL LINE; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; VIRUS REPLICATION; WESTERN BLOTTING;

GASTROPODA; HUMAN IMMUNODEFICIENCY VIRUS 1;

BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CELL LINE; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; IMMUNOPRECIPITATION; PROTEIN BINDING; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 41949097370     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00430-07     Document Type: Article

References (66)

1. Amit, S., A. Hatzubai, Y. Birman, J. S. Andersen, E. Ben-Shushan, M. Mann, Y. Ben-Neriah, and I. Alkalay. 2002. Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 16:1066-1076.
2. Balliet, J. W., D. L. Kolson, G. Eiger, F. M. Kim, K. A. McGann, A. Srinivasan, and R. Cullman. 1994. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 200:623-631.
3. βTrCP substrates. J. Biol. Chem. 279:788-795.
4. Binette, J., M. Dube, J. Mercier, and E. A. Cohen. 2007. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 4:75.
5. Bour, S., C. Perrin, H. Akari, and K. Strebel. 2001. The human immunodeficiency virus type 1 Vpu protein inhibits NF-κB activation by interfering with βTrCP-mediated degradation of IκB. J. Biol. Chem. 276:15920-15928.
6. Burleigh, L., P.-Y. Lozach, C. Schiffer, I. Staropoli, V. Pezo, F. Porrot, B. Cangque, J.-L. Virelizier, F. Arenzana-Seisdedos, and A. Amara. 2006. Infection of dendritic cells (DCs), not DC-SlGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol. 80:2949-2957.
7. Butticaz, C., O. Michielin, J. Wyniger, A. Telenti, and S. Rothenberger. 2007. Silencing of both β-TrCP1 and HOS (β-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation. J. Virol. 81:1502-1505.
8. Caca, K., F. T. Kolligs, X. Ji, M. Hayes, J.-M. Qian, A. Yahanda, D. L. Rimm, J. Costa, and E. R. Fearon. 1999. β- and γ-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ. 10:369-376.
9. Cano, A., M. A. Pérez-Moreno, I. Rodrigo, A. Locascio, M. J. Blanco, M. G. del Barrio, F. Portillo, and M. A. Nieto. 2000. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2:76-83.
10. Cha, M. Y., C. M. Kim, Y. M. Park, and W. S. Ryu. 2004. Hepatitis B virus X protein is essential for the activation of Wnt/β-catenin signaling in hepatoma cells. Hepatology 39:1683-1693.
11. Chan, W.-E., and S.-L. Chen. 2006. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein. Virology 348:418-429.
12. Chen, C., O. A. Weisz, D. B. Stolz, S. C. Watkins, and R. C. Montelaro. 2004. Differential effects of actin cytoskeleton dynamics on equine infectious anemia virus particle production. J. Virol. 78:882-891.
13. Cohen, E. A., R. A. Subbramanian, and H. G. Gottlinger. 1996. Role of auxiliary proteins in retroviral morphogenesis. Curr. Top. Microbiol. Immu nol. 214:219-235.
14. Courgnaud, V., B. Abela, X. Pourrut, E. Mpoudi-Ngole, S. Loul, E. Delaporte, and M. Peeters. 2003. Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different Cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. J. Virol. 77:12523-12534.
15. Courgnaud, V., M. Salemi, X. Pourrut, E. Mpoudi-Ngole, B. Abela, P. Auzel, F. Bibollet-Ruche, B. Hahn, A.-M. Vandamme, E. Delaporte, and M. Peeters. 2002. Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. J. Virol. 76:8298-8309.
16. Dazza, M. C., M. Ekwalanga, M. Nende, K. B. Shamamba, P. Bitshi, D. Parskevis, and S. Saragosti. 2005. Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti). J. Virol. 79:8560-8571.
17. Deora, A., and L. Ratner. 2001. Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation. J. Virol. 75:6714-6718.
18. Dietrich, C., J. Scherwat, D. Faust, and F. Oesch. 2002. Subcellular localization of β-catenin is regulated by cell density. Biochem. Biophys. Res. Commun. 292:195-199.
19. Dingwell, K. S., and D. C. Johnson. 1998. The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J. Virol. 72:8933-8942.
20. Estrabaud, E., E. LeRouzic, S. Lopez-Vergès, M. Morel, N. Belaïdouni, R. Benarous, C. Transy, C. Berlioz-Torrent, and F. Margottin-Goguet. 2007. Regulated degradation of the HIV-1 Vpu protein through a βTrCP-independent pathway limits the release of viral particles. PLOS Pathog. 27:e104.
21. Geraghty, R. J., K. J. Talbot, M. Callahan, W. Haper, and A. T. Panganiban. 1994. Cell type-dependence for Vpu function. J. Med. Primatol. 23:146-150.
22. cpz strains. Virology 335:46-60.
23. Gorry, P. R., M. Churchill, S. M. Crowe, A. L. Cunningham, and D. Gabuzda. 2005. Pathogenesis of macrophage-tropic HIV. Curr. HIV Res. 3:53-60.
24. Gottlinger, H. G., T. Dorfman, E. A Cohen, and W. A. Haseltine. 1993. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsid produced by the Gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA 90:7381-7385.
25. Guironnet, G., C. Dezutter-Dambuyant, C. Vincent, N. Bechetoille, D. Schmitt, and J. Péguet-Navarro. 2002. Antagonistic effects of IL-4 and TGF-β1 on Langerhans cell-related antigen expression by human monocytes. J. Leukoc. Biol. 71:845-853.
26. Gumbiner, B. M. 1996. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357.
27. Hairla, K., A. Salminen, I. Prior, J. Hinkula, and M. Soumalainen. 2007. The Vpu-regulated endocytosis of HIV-1 Gag is clathrin-independent. Virology 369:299-308.
28. Hart, M., J.-P. Concordet, I. Lasset, I. Albert, R. del los Santos, H. Durand, C. Perret, B. Rubinfeld, F. Margottin, R. Benarous, and P. Polakis. 1999. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr. Biol. 9:207-210.
29. Hayward, S. D., J. Liu, and M. Fujimuro. 2006. Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses. Sci. STKE 335:re4.
30. Hsu, K., J. Seharaseyon, P. Dong, S. Bour, and E. Marbán. 2004. Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel. Mol. Cell 14:259-267.
31. Hu, P., E. J. O'Keefe, and D. S. Rubenstein. 2001. Tyrosine phosphorylation of human keratinocyte β-catenin and plakoglobin reversibly regulates their binding to E-cadherin and α-catenin. J. Investig. Dermatol. 117:1059-1067.
32. Jolly, C., K. Kashefi, M. Hollinshead, and Q. J. Sattentau. 2004. HIV-1 cell-to-cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199:283-298.
33. Kim, E. M., K. H. Lee, and J. W. Kim. 1999. The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin. Mol. Cell 9:281-285.
34. Maldarelli, F., M. Y. Chen, R. L. Willey, and K. Strebel. 1993. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type 1 integral membrane protein. J. Virol. 67:5056-5061.
35. Marassi, F. M., C. Ma, H. Gratkowski, S. K. Straus, K. Strebel, M. Oblatt-Montal, M. Montal, and S. J. Opella. 1999. Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proc. Natl. Acad. Sci. USA 96:14336-14441.
36. Margottin, F., S. P. Bour, H. Durand, L. Selig, S. Benichou, V. Richard, D. Thomas, K. Strebel, and R. Benarous. 1998. A novel human WD protein, h-βTrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1:565-574.
37. Menges, M., T. Baumeister, S. Rossner, P. Stoitzner, N. Romani, A. Gessnere, and M. B. Lutz. 2005. IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J. Leukoc. Biol. 77:535-543.
38. Neil, S. J. D., S. W. Eastman, N. Jouvenet, and P. D. Bieniasz. 2006. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLOS Pathog. 2:354-366.
39. Nguyen, K. L., M. Ilano, H. Akari, E. Miyagi, E. M. Poeschla, K. Strebel, and S. Bour. 2004. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology 319:163-175.
40. Ozawa, H., H. Baribault, and R. Kemler. 1989. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1711-1717.
41. Park, C. L., I. M. Kim, M. S. Lee, C.-y. Youn, D. J. Kim, E.h. Jho, and W. K. Song. 2004. Modulation of β-catenin phosphorylation/ degradation by cyclin-dependent kinase 2. J. Biol. Chem. 279:19592-19599.
42. Qiang, Y. W., and S. Rudikoff. 2004. Wnt signaling in B and T lymphocytes. Frontiers Biosci. 9:1000-1010.
43. Raja, N. U., and M. A. Jabbar. 1996. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function. Virology 220:141-151.
44. Sadot, E., M. Canacci-Sorrell, J. Zhurinsky, D. Shnizere, Z. Lando, D. Zharhary, Z. Kam, A. Ben-ze'ev, and B. Geiger. 2002. Regulation of S33/S37 phosphorylated β-catenin in normal and transformed cells. J. Cell Sci. 115:2771-2780.
45. Sakai, H., K. Tokunaga, M. Kawamura, and A. Adachi. 1995. Function of human immunodeficiency virus type 1 Vpu protein in various cell types. J. Gen. Virol. 76:2717-2722.
46. Schubert, U., S. Bour, A. V. Ferrer-Montiel, M. Montal, F. Maldarelli, and K. Strebel. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:809-819.
47. Schubert, U., K. A. Clouse, and K. Strebel. 1995. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69:7699-7711.
48. Schubert, U., P. Henklein, B. Boldyreff, E. Wingender, K. Strebel, and T. Porstmann. 1994. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted α-helix-turn-α-helix-motif. J. Mol. Biol. 236:16-25.
49. Schubert, U., and K. Strebel. 1994. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:2260-2271.
50. Schwarzenberger, K., and M. C. Udey. 1996. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Investig. Dermatol. 106:553-558.
51. Schweneker, M., A. S. Bachmann, and K. Moelling. 2004. The HIV-1 co-receptor CCR5 binds to α-catenin, a component of the cellular cytoskeleton. Biochem. Biophys. Res. Commun. 325:751-757.
52. Spearman, P., J.-J. Wang, N. VanderHeyden, and L. Ratner. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242.
53. Staal, F. J. T., M. van Noort, G. J. Strous, and H. C. Clevers. 2002. Wnt signals are transmitted through N-terminally dephosphorylated β-catenin. EMBO Rep. 3:63-68.
54. Stephens, E. B., C. McCormick, E. Pacyniak, D. Griffin, D. M. Pinson, F. Sun, W. Notnick, S. W. Wong, R. Gunderson, N. E. Berman, and D. K. Singh. 2002. Deletion of the Vpu sequences prior to the Env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques. Virology 293:252-261.
55. Strebel, K., T. Klimkait, and M. A. Martin. 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241:1221-1223.
56. Taurin, S., N. Sandbo, Y. Qin, D. Browning, and N. O. Dulin. 2006. Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase. J. Biol. Chem. 281:9971-9976.
57. Troyanovsky, R. B., E. Sokolov, and S. M. Troyanovsky. 2003. Adhesive and lateral E-cadherin dimers are mediated by the same interface. Mol. Cell. Biol. 23:7965-7972.
58. Tsai, C. N., C. L. Tsai, K. P. Tse, H. Y. Chang, and Y. S. Chang. 2002. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl. Acad. Sci. USA 99:10084-10089.
59. Varthakavi, V., R. M. Smith, S. P. Bour, K. Strebel, and P. Spearman. 2003. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc. Natl. Acad. Sci. USA 100:15154-15159.
60. Varthakavi, V., R. M. Smith, K. L. Martin, D. Deredowski, A. Lapierre, R. R. Goldenring, and P. Spearman. 2006. The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release. Traffic 7:298-307.
61. Verma, U. N., R. M. Surabhi, A. Schmaltieg, C. Becerra, and R. B. Gaynor. 2003. Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res. 9:1291-1300.
62. Westervelt, P., T. Henkel, D. B. Trowbridge, J. Orenstein, J. Heuser, H. E. Gendelman, and L. Ratner. 1992. Dual regulation of silent and productive infection in monocytes by distinct HIV-1 determinants. J. Virol. 66:3925-3931.
63. Wheelock, J. M., K. A. Knudsen, and K. R. Johnson. 1996. Membrane-cytoskeletal interactions with cadherin and cell adhesion proteins: role of catenins as linker proteins. Curr. Topics Microbiol. Immunol. 43:169-185.
64. Yook, J. I., X. Y. Li, I. Ota, E. R. Fearon, and S. J. Weiss. 2005. Wnt-dependent regulation of the E-cadherin repressor snail. J. Biol. Chem. 280: 11740-11748.
65. Yoon, M., and P. G. Spear. 2002. Disruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry. J. Virol. 76:7203-7208.
66. Zhang, L., Y. Huang, H. Yuan, S. Tuttleton, and D. D. Ho. 1997. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology 228:340-349.